Home › Blindness › Illinois
Blindness clinical trials in Illinois
4 studies for Blindness are looking for participants at sites in Illinois.
Cities in Illinois
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
- Adverum Clinical Site 246, Chicago
- Adverum Clinical Site 179, Oak Forest
- Adverum Clinical Site 207, Oak Park
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Sep 24, 2026 · NCT07482176Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 179, Lemont
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
- Illinois Tech, Chicago
Recruiting
Ages 19 to 70 · All sexes · Updated Jun 3, 2026 · NCT04634383Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
- The Chicago Lighthouse, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Jul 30, 2025 · NCT07073521From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.